CBX Therapeutics is a California-based biotechnology company focused on developing innovative, cannabinoid-based solutions for neurological and neurodegenerative disorders.

We are dedicated to providing immediate relief for patients suffering from Parkinson’s disease, primarily through our fast-acting oral disintegrating tablet, TPP-1, and are simultaneously advancing research into broader neuroprotection.

CBX Therapeutics distinguishes itself through a rigorous, translational approach, combining scientific precision with a commitment to real-world clinical relevance. Our platform, CLARIFY, utilizes combinatorial discovery, predictive modeling, and a lean execution framework to accelerate the development of targeted therapies. We welcome collaboration with clinical sites, distribution partners, and wellness brands who share our dedication to scientific integrity and patient-centered outcomes.

TPP-1 | CBX Therapeutics

Product description

CBX Therapeutics Beer Sheva, Israel

Price: N/A

CBX Therapeutics
Beer Sheva, Israel